85 related articles for article (PubMed ID: 20970672)
21. Stromal cell-derived factor-1-3'A polymorphism is associated with decreased risk of myocardial infarction and early endothelial disturbance.
Borghini A; Sbrana S; Vecoli C; Mercuri A; Turchi S; Carpeggiani C; L'Abbate A; Andreassi MG
J Cardiovasc Med (Hagerstown); 2014 Sep; 15(9):710-6. PubMed ID: 24751515
[TBL] [Abstract][Full Text] [Related]
22. Molecular investigation of the stromal cell-derived factor-1 chemokine in lymphoid leukemia and lymphoma patients from Brazil.
de Oliveira Cavassin GG; De Lucca FL; Delgado André N; Covas DT; Pelegrinelli Fungaro MH; Voltarelli JC; Watanabe MA
Blood Cells Mol Dis; 2004; 33(1):90-3. PubMed ID: 15223017
[TBL] [Abstract][Full Text] [Related]
23. Human bone marrow mesenchymal stem cells expressing SDF-1 promote hematopoietic stem cell function of human mobilised peripheral blood CD34+ cells in vivo and in vitro.
Liang X; Su YP; Kong PY; Zeng DF; Chen XH; Peng XG; Zou ZM; Xu H
Int J Radiat Biol; 2010 Mar; 86(3):230-7. PubMed ID: 20201651
[TBL] [Abstract][Full Text] [Related]
24. Cytokine-primed bone marrow stem cells vs. peripheral blood stem cells for autologous transplantation: a randomized comparison of GM-CSF vs. G-CSF.
Weisdorf D; Miller J; Verfaillie C; Burns L; Wagner J; Blazar B; Davies S; Miller W; Hannan P; Steinbuch M; Ramsay N; McGlave P
Biol Blood Marrow Transplant; 1997 Oct; 3(4):217-23. PubMed ID: 9360784
[TBL] [Abstract][Full Text] [Related]
25. The role of a stromal cell-derived factor-1 chemokine gene variant in the clinical course of HIV-1 infection.
van Rij RP; Broersen S; Goudsmit J; Coutinho RA; Schuitemaker H
AIDS; 1998 Jun; 12(9):F85-90. PubMed ID: 9662191
[TBL] [Abstract][Full Text] [Related]
26. Plasma levels of FL and SDF-1 and expression of FLT-3 and CXCR4 on CD34+ cells assessed pre and post hematopoietic stem cell mobilization in patients with hematologic malignancies and in healthy donors.
Cecyn KZ; Schimieguel DM; Kimura EY; Yamamoto M; Oliveira JS
Transfus Apher Sci; 2009 Jun; 40(3):159-67. PubMed ID: 19380254
[TBL] [Abstract][Full Text] [Related]
27. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease.
Heeschen C; Lehmann R; Honold J; Assmus B; Aicher A; Walter DH; Martin H; Zeiher AM; Dimmeler S
Circulation; 2004 Apr; 109(13):1615-22. PubMed ID: 15037527
[TBL] [Abstract][Full Text] [Related]
28. Plasma stromal cell-derived factor-1 during granulocyte colony-stimulating factor-induced peripheral blood stem cell mobilization.
Kozuka T; Ishimaru F; Fujii K; Masuda K; Kaneda K; Imai T; Fujii N; Ishikura H; Hongo S; Watanabe T; Shinagawa K; Ikeda K; Niiya K; Harada M; Tanimoto M
Bone Marrow Transplant; 2003 Apr; 31(8):651-4. PubMed ID: 12692604
[TBL] [Abstract][Full Text] [Related]
29. Elevated plasma stromal cell-derived factor 1 protein and its gene polymorphism in patients with pelvic inflammatory disease.
Tsai HT; Tee YT; Hsieh YH; Chiou HL; Lin CW; Tsai HC; Wang PH; Yang SF
Reprod Sci; 2009 Jun; 16(6):610-7. PubMed ID: 19282275
[TBL] [Abstract][Full Text] [Related]
30. Peripheral blood progenitor cell transplantation: a single centre experience comparing two mobilisation regimens in 67 patients.
Mahendra P; Johnson D; Scott MA; Jestice HK; Hood IM; Ager S; Bass G; Barker P; Boraks PA; Bloxham DM; Baglin TP; Marcus RE
Bone Marrow Transplant; 1996 Apr; 17(4):503-7. PubMed ID: 8722346
[TBL] [Abstract][Full Text] [Related]
31. Analysis of factors predicting speed of hematologic recovery after transplantation with 4-hydroperoxycyclophosphamide-purged autologous bone marrow grafts.
Rowley SD; Piantadosi S; Marcellus DC; Jones RJ; Davidson NE; Davis JM; Kennedy J; Wiley JM; Wingard JR; Yeager AM
Bone Marrow Transplant; 1991 Mar; 7(3):183-91. PubMed ID: 2059755
[TBL] [Abstract][Full Text] [Related]
32. Comparison of haematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplants.
To LB; Roberts MM; Haylock DN; Dyson PG; Branford AL; Thorp D; Ho JQ; Dart GW; Horvath N; Davy ML
Bone Marrow Transplant; 1992 Apr; 9(4):277-84. PubMed ID: 1350938
[TBL] [Abstract][Full Text] [Related]
33. Beneficial effect of the CXCL12-3'A variant for patients undergoing hematopoietic stem cell transplantation from unrelated donors.
Bogunia-Kubik K; Mizia S; Polak M; Gronkowska A; Nowak J; Kyrcz-Krzemień S; Markiewicz M; Dzierżak-Mietła M; Koclęga A; Sędzimirska M; Suchnicki K; Duda D; Lange J; Mordak-Domagała M; Kościńska K; Jędrzejczak WW; Kaczmarek B; Hellmann A; Kucharska A; Kowalczyk J; Drabko K; Warzocha K; Hałaburda K; Tomaszewska A; Mika-Witkowska R; Witkowska A; Goździk J; Mordel A; Wysoczańska B; Jaskula E; Lange A;
Cytokine; 2015 Dec; 76(2):182-186. PubMed ID: 25982843
[TBL] [Abstract][Full Text] [Related]
34. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
[TBL] [Abstract][Full Text] [Related]
35. Distribution of two HIV-1-resistant polymorphisms (SDF1-3'A and CCR2-64I alleles) in the Polish population.
Lewandowska M; Franciszkiewicz K; Prokop J; Ofori H; Jagodzinski PP
J Hum Genet; 2002; 47(11):585-9. PubMed ID: 12436194
[TBL] [Abstract][Full Text] [Related]
36. Rapid engraftment after allogeneic transplantation of density-enriched peripheral blood CD34+ cells in patients with advanced hematologic malignancies.
Cao TM; Kusnierz-Glaz C; Valone F; Stockerl-Goldstein KE; Hu WW; Johnston L; Blume KG; Strober S; Negrin RS
Cancer; 2001 Jun; 91(12):2205-13. PubMed ID: 11413507
[TBL] [Abstract][Full Text] [Related]
37. [CD34+ cell dose and hematologic recovery in allogeneic peripheral blood stem cell transplantation].
Sawada H; Wake A; Yamasaki Y; Izumi Y
Rinsho Ketsueki; 2000 Jun; 41(6):500-6. PubMed ID: 10921350
[TBL] [Abstract][Full Text] [Related]
38. Peripheral blood stem cell transplantation as an alternative to autologous marrow transplantation in the treatment of acute myeloid leukemia?
Vellenga E; van Putten WL; Boogaerts MA; Daenen SM; Verhoef GE; Hagenbeek A; Jonkhoff AR; Huijgens PC; Verdonck LF; van der Lelie J; Schouten HC; Gmür J; Wijermans P; Gratwohl A; Hess U; Fey MF; Löwenberg B
Bone Marrow Transplant; 1999 Jun; 23(12):1279-82. PubMed ID: 10414916
[TBL] [Abstract][Full Text] [Related]
39. Progenitor content of autologous grafts: mobilized bone marrow vs mobilized blood.
Dahl E; Burroughs J; DeFor T; Verfaillie C; Weisdorf D
Bone Marrow Transplant; 2003 Sep; 32(6):575-80. PubMed ID: 12953129
[TBL] [Abstract][Full Text] [Related]
40. Endothelial-like vascular progenitor cells (VPCs) from allogeneic and autologous donors: mobilization features distinct from hematopoietic progenitors.
Allan DS; Dubé P; Roy J; Busque L; Roy DC
Biol Blood Marrow Transplant; 2007 Apr; 13(4):433-9. PubMed ID: 17382249
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
